Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

Anti-VEGF injections were independently associated with a higher likelihood of developing any systemic AE (OR 1.8, 95% CI 1.7-1.9) after controlling for a number of factors including age, sex ...

Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach.

What type of eye injections exist for treating diabetic retinopathy? Anti-VEGF (vascular endothelial growth factor) drugs are the main type of eye injections to treat diabetic retinopathy.

Greater vision improvements were seen in people with macular edema secondary to retinal vein occlusion who received more anti-VEGF injections over the course of 5 years.

Adherence to intravitreal anti-VEGF injections may be challenging for some patients with neovascular age-related macular degeneration, putting them at risk for poor vision outcomes, according to ...

The demand for intravitreal vascular endothelial growth factor (VEGF) inhibitor therapy is forecasted to increase by about 50% over the next 5 years in Denmark, due largely to an aging population ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.

SEATTLE — A study based on IRIS Registry data delved into the rates, risk factors, management strategies and outcomes of post-intravitreal anti-VEGF injection endophthalmitis.

Adverum Biotechnologies presented 26-week interim data from the LUNA Phase 2 trial for Ixo-vec in wet AMD. The analysis showed significant reductions in anti-VEGF injections and positive visual ...